Ligand Pharmaceuticals announced it will acquire biotech company APEIRON Biologics for $100 million. The all-cash deal includes an additional $28 million if APEIRON’s royalties exceed predetermined thresholds by either 2030 or 2034, respectively, and is subject to a 30 day shareholder objection period. Based in Austria, APEIRON holds...

Listen as intellectual property attorneys Tiffany Gehrke and Kelley Gordon of Marshall Gerstein in Chicago share their insights into three matters relevant anyone watching copyright and trademark law, or anyone fond of branded t-shirts and fancy French beverages. I talk...